Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles

Journal of Nanobiotechnology

Volumn 14, Issue 1, 2016, Pages

  Sulheim, Einar ^a   Baghirov, Habib ^a   Haartman, Eva ^a,c   Bøe, Andreas ^a   Åslund, Andreas K O ^a   Mørch, Yrr ^b   Davies, Catharina de Lange ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b SINTEF MATERIALS AND CHEMISTRY   (Norway)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

Degradation; Fluorescence lifetime; Intracellular delivery; Nanoparticles; Poly(alkyl cyanoacrylate)

Indexed keywords

ADHESIVES; CELL CULTURE; CELLS; CYTOLOGY; DEGRADATION; DISEASES; DRUG DELIVERY; DRUG PRODUCTS; EMISSION SPECTROSCOPY; ENDOTHELIAL CELLS; ENERGY TRANSFER; FLUORESCENCE; GAS CHROMATOGRAPHY; HYDROPHOBICITY; MOLECULAR BIOLOGY; MONOMERS; PHOTODEGRADATION; SCANNING ELECTRON MICROSCOPY;

CYANOACRYLATES; FLUORESCENCE LIFETIME IMAGING; FLUORESCENCE LIFETIMES; INTRACELLULAR DEGRADATION; INTRACELLULAR DELIVERY; INTRACELLULAR DRUG DELIVERY; POLY(BUTYL CYANOACRYLATE); RESONANCE ENERGY TRANSFER;

NANOPARTICLES;

FLUORESCENT DYE; NANOPARTICLE; NILE RED 668; POLY(ALKYL CYANOACRYLATE)NANOPARTICLE; POLY(BUTYL CYANOACRYLATE)NANOPARTICLE; POLY(OCTYL CYANOACRYLATE)NANOPARTICLE; POLYMER; UNCLASSIFIED DRUG; CYANOACRYLATE DERIVATIVE; DRUG; DRUG CARRIER;

ARTICLE; CAVEOLIN MEDIATED ENDOCYTOSIS; CHEMICAL ANALYSIS; CLATHRIN MEDIATED ENDOCYTOSIS; CONTROLLED STUDY; DEGRADATION; DRUG DELIVERY SYSTEM; EMISSION SPECTRA ANALYSIS; ENDOCYTOSIS; ENDOTHELIUM CELL; FLUORESCENCE IMAGING; FLUORESCENCE RESONANCE ENERGY TRANSFER; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTRACELLULAR DEGRADATION; INTRACELLULAR TRANSPORT; PC3 CELL LINE; PROSTATE CANCER CELL LINE; RBE4 CELL LINE; SCANNING ELECTRON MICROSCOPY; ANIMAL; BRAIN; CHEMICAL PHENOMENA; DRUG RELEASE; FLUORESCENCE; MALE; METABOLISM; PHYSIOLOGY; PROCEDURES; PROSTATE TUMOR; RAT; TUMOR CELL LINE;

ANIMALS; BRAIN; CELL LINE, TUMOR; CYANOACRYLATES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; ENDOCYTOSIS; FLUORESCENCE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MALE; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; PROSTATIC NEOPLASMS; RATS;

EID: 84953387445     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/s12951-015-0156-7     Document Type: Article

References (55)

1. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005;5:161-71.
2. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer-chemotherapy-mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387-92.
3. Iversen TG, Skotland T, Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today. 2011;6:176-85.
4. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. 2000;60:6950-7.
5. Husseini GA, Pitt WG. Ultrasonic-activated micellar drug delivery for cancer treatment. J Pharm Sci. 2009;98:795-811.
6. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75:1-18.
7. Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov. 2014;13:813-27.
8. Soma E, Attali P, Merle P. A Clinically Relevant Case Study: the Development of Livatag® for the Treatment of Advanced Hepatocellular Carcinoma. In: Alonso MJ, Csaba NS, editors. Nanostructured Biomaterials for Overcoming Biological Barriers. The Royal Society of Chemistry; 2012. p.591-600.
9. Mørch Y, Hansen R, Berg S, Åslund AKO, Glomm WR, Eggen S, Schmid R, Johnsen H, Kubowicz S, Snipstad S, et al. Nanoparticle-stabilized microbubbles for multimodal imaging and drug delivery. Contrast Media and Molecular imaging 2015;10:356-66.
10. Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Del Rev. 2003;55:519-48.
11. Tomcin S, Baier G, Landfester K, Mailander V. Pharmacokinetics on a microscale: visualizing Cy5-labeled oligonucleotide release from poly(n-butylcyanoacrylate) nanocapsules in cells. Int J Nanomedicine. 2014;9:5471-89.
12. Muller RH, Lherm C, Herbort J, Blunk T, Couvreur P. Alkylcyanoacrylate drug carriers. 1. physicochemical characterization of nanoparticles with different alkyl chain-length. Int J Pharm. 1992;84:1-11.
13. Huang CY, Lee YD. Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation. Int J Pharm. 2006;325:132-9.
14. Wade CWR, Leonard F. Degradation of poly(methyl 2-cyanoacrylates). J Biomed Mater Res. 1972;6:215-20.
15. Scherer D, Robinson JR, Kreuter J. Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles. Int J Pharm. 1994;101:165-8.
16. Lenaerts V, Couvreur P, Christiaensleyh D, Joiris E, Roland M, Rollman B, Speiser P. Degradation of poly (isobutyl cyanoacrylate) nanoparticles. Biomaterials. 1984;5:65-8.
17. Muller RH, Lherm C, Herbort J, Couvreur P. In vitro model for the degradation of alkylcyanoacrylate nanoparticles. Biomaterials. 1990;11:590-5.
18. Leonard F, Kulkarni RK, Brandes G, Nelson J, Cameron JJ. Synthesis and degradation of poly(alkyl alpha-cyanoacrylates). J Appl Polym Sci. 1966;10:259-72.
19. Vansnick L, Couvreur P, Christiaens-Leyh D, Roland M. Molecular weights of free and drug-loaded nanoparticles. Pharm Res. 1985;2:36-41.
20. Andrieux K, Couvreur P. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1:463-74.
21. Klymchenko AS, Roger E, Anton N, Anton H, Shulov I, Vermot J, Mely Y, Vandamme TF. Highly lipophilic fluorescent dyes in nano-emulsions: towards bright non-leaking nano-droplets. RSC Adv. 2012;2:11876-86.
22. Eggen S, Fagerland SM, Morch Y, Hansen R, Sovik K, Berg S, Furu H, Bohn AD, Lilledahl MB, Angelsen A, et al. Ultrasound-enhanced drug delivery in prostate cancer xenografts by nanoparticles stabilizing microbubbles. J Controll Release. 2014;187:39-49.
23. Romero G, Qiu Y, Murray RA, Moya SE. Study of intracellular delivery of doxorubicin from poly(lactide-co-glycolide) nanoparticles by means of fluorescence lifetime imaging and confocal raman microscopy. Macromol Biosci. 2013;13:234-41.
24. Luhmann T, Rimann M, Bitterman AG, Hall H. Cellular uptake and intracellular pathways of PLL-g-PEG-DNA nanoparticles. Bioconj Chem. 2008;19:1907-16.
25. Snipstad S, Westrom S, Morch Y, Afadzi M, Aslund A, de Lange Davies C. Contact-mediated intracellular delivery of hydrophobic drugs from polymeric nanoparticles. Cancer Nanotechnol. 2014;5:8.
26. Bennis S, Chapey C, Couvreur P, Robert J. Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumor-cells in culture. Eur J Cancer. 1994;30A:89-93.
27. Fattal E, Vauthier C, Aynie I, Nakada Y, Lambert G, Malvy C, Couvreur P. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. J Controll Release. 1998;53:137-43.
28. Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev. 2014;71:2-14.
29. deVerdiere AC, Dubernet C, Nemati F, Soma E, Appel M, Ferte J, Bernard S, Puisieux F, Couvreur P. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: Towards a mechanism of action. Br J Cancer. 1997;76:198-205.
30. Evangelatov A, Skrobanska R, Mladenov N, Petkova M, Yordanov G, Pankov R. Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells. Drug Deliv. 2014:1-10.
31. Yordanov G, Evangelatov A, Skrobanska R. Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: preparation and in vitro evaluation in human lung adenocarcinoma cells. Colloids Surf B Biointerfaces. 2013;107:115-23.
32. Lira MCB, Santos-Magalhaes NS, Nicolas V, Marsaud V, Silva MPC, Ponchel G, Vauthier C. Cytotoxicity and cellular uptake of newly synthesized fucoidan-coated nanoparticles. Eur J Pharm Biopharm. 2011;79:162-70.
33. Chithrani BD, Chan WCW. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007;7:1542-50.
34. He CB, Hu YP, Yin LC, Tang C, Yin CH. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31:3657-66.
35. dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA. Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small. 2011;7:3341-9.
36. Ramge P, Unger RE, Oltrogge JB, Zenker D, Begley D, Kreuter J, von Briesen H. Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells. Eur J Neurosci. 2000;12:1931-40.
37. Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 2002;16.
38. dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One. 2011;6:e24438.
39. You JO, Auguste DT. Feedback-regulated paclitaxel delivery based on poly(N, N-dimethylaminoethyl methacrylate-co-2-hydroxyethyl methacrylate) nanoparticles. Biomaterials. 2008;29:1950-7.
40. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem Rev. 2011;111:5610-37.
41. Zweers MLT, Engbers GHM, Grijpma DW, Feijen J. In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide). J Controll Release. 2004;100:347-56.
42. Lao LL, Peppas NA, Boey FYC, Venkatraman SS. Modeling of drug release from bulk-degrading polymers. Int J Pharm. 2011;418:28-41.
43. Grangier JL, Puygrenier M, Gautier JC, Couvreur P. Nanoparticles as carriers for growth-hormone releasing-factor. J Controll Release. 1991;15:3-13.
44. Hansali F, Poisson G, Wu M, Bendedouch D, Marie E. Miniemulsion polymerizations of n-butyl cyanoacrylate via two routes: towards a control of particle degradation. Colloids Surf B Biointerfaces. 2011;88:332-8.
45. Gravier J, Sancey L, Hirsjärvi S, Rustique E, Passarini C, Benoit JP, Coll JL, Texier I. FRET Imaging Approaches for in vitro and in vivo characterization of synthetic lipid nanoparticles. Mol Pharm. 2014.
46. Kante B, Couvreur P, Dubois-Krack G, De Meester C, Guiot P, Roland M, Mercier M, Speiser P. Toxicity of polyalkylcyanoacrylate nanoparticles I: free nanoparticles. J Pharm Sci. 1982;71:786-90.
47. Lherm C, Muller RH, Puisieux F, Couvreur P. Alkylcyanoacrylate drug carriers. 2. cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain-length. Int J Pharm. 1992;84:13-22.
48. Gillies ER, Goodwin AP, Frechet JMJ. Acetals as pH-sensitive linkages for drug delivery. Bioconj Chem. 2004;15:1254-63.
49. Zhao YM, van Rooy I, Hak S, Fay F, Tang J, Davies CD, Skobe M, Fisher EA, Radu A, Fayad ZA, et al. Near-infrared fluorescence energy transfer imaging of nanoparticle accumulation and dissociation kinetics in tumor-bearing Mice. ACS Nano. 2013;7:10362-70.
50. Bastiaens PIH, Squire A. Fluorescence lifetime imaging microscopy: spatial resolution of biochemical processes in the cell. Trends Cell Biol. 1999;9:48-52.
51. Sanders R, Draaijer A, Gerritsen HC, Houpt PM, Levine YK. Quantitative Ph imaging in cells using confocal fluorescence lifetime imaging microscopy. Anal Biochem. 1995;227:302-8.
52. Skotland T, Iversen TG, Sandvig K. Development of nanoparticles for clinical use. Nanomedicine. 2014;9:1295-9.
53. Barua S, Rege K. Cancer-cell-phenotype-dependent differential intracellular trafficking of unconjugated quantum dots. Small. 2009;5:370-6.
54. Davis JN, Kucuk O, Sarkar FH. Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr Cancer Int J. 1999;35:167-74.
55. Åslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, Dickstein DL, Glimsdal E, Prokop S, Lindgren M, Konradsson P, et al. Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol. 2009;4:673-84.